lysine has been researched along with organophosphonates in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Morley, CG; Stadtman, TC | 1 |
| Bleiweis, AS; Krause, RM; Young, FE | 1 |
| Célérier, J; Corvol, P; Iturrioz, X; Llorens-Cortès, C; Vazeux, G | 1 |
| Bangale, Y; Bhatia, G; Karle, S; Mitsuda, Y; Nishiyama, Y; Paul, S; Planque, S; Taguchi, H | 1 |
| Bacheler, L; Koontz, D; Mellors, JW; Parikh, UM | 1 |
| Mellors, JW; Parikh, UM; Sheen, CW; Sluis-Cremer, N; Torres, PS; Zelina, S | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T; Ozawa, Y; Taguchi, K | 1 |
| Calvez, V; Flandre, P; Fofana, DB; Fourati, S; Katlama, C; Lambert, S; Malet, I; Marcelin, AG; Sayon, S; Simon, A; Soulie, C; Wirden, M | 1 |
| Gordon, M; Hampton, J; Johnson, B; Kuritzkes, DR; Marconi, VC; Moosa, MY; Ordonez, C; Sunpath, H; Wu, B | 1 |
| Arribas, JR; Bernardino, JI; Estebanez, M; García-Bujalance, S; Martin-Quirós, A; Mingorance, J; Pérez-Valero, I; Ruiz-Carrascoso, G; Stella-Ascariz, N; Zamora, FX | 1 |
| Charbonnière, LJ; Christine, C; Clavier, S; Ehret-Sabatier, L; Koubemba, M; Orend, G; Saupe, F; Shakir, S | 1 |
| Fukuyama, K; Han, L; Hiratake, J; Kamiyama, A; Kojima-Yuasa, A; Matsui-Yuasa, I; Mizutani, M; Nakajima, M; Suzuki, H; Tabuchi, Y; Wada, K; Watanabe, B | 1 |
| Drzezga, A; Gorin, MA; Pomper, MG; Rowe, SP; Salas Fragomeni, RA | 1 |
| Chu, Y; Hengge, AC; Williams, NH | 1 |
| Bier, D; Briels, J; Guillory, X; Kaiser, M; Ottmann, C; Ruiz-Blanco, YB; Sanchez-Garcia, E; Yilmaz, E | 1 |
| Gómez-Peña, A; Horcajada, P; Salcedo-Abraira, P; Salles, F; Trens, P; Várez, A; Vilela, SMF | 1 |
1 review(s) available for lysine and organophosphonates
| Article | Year |
|---|---|
Clinical Experience with
Topics: Antigens, Surface; Cysteine; Drug Evaluation, Preclinical; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Glutarates; Humans; Lysine; Male; Organophosphonates; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urea | 2017 |
15 other study(ies) available for lysine and organophosphonates
| Article | Year |
|---|---|
Studies on the fermentation of D-alpha-lysine. Purification and properties of an adenosine triphosphate regulated B 12-coenzyme-dependent D-alpha-lysine mutase complex from Clostridium sticklandii.
Topics: Adenosine Triphosphate; Alkylating Agents; Aminocaproates; Bacterial Proteins; Carbon Isotopes; Chromatography, Gel; Chromatography, Ion Exchange; Clostridium; Electrophoresis, Disc; Hydrogen-Ion Concentration; Iodoacetates; Isomerases; Light; Lysine; Magnesium; Organophosphonates; Ornithine; Potassium; Pyridoxal Phosphate; Quaternary Ammonium Compounds; Radiation Effects; Spectrophotometry; Stereoisomerism; Sulfhydryl Compounds; Temperature; Time Factors; Ultraviolet Rays; Vitamin B 12 | 1970 |
Cell walls of group D streptococci. II. Chemical studies on the type 1 antigen purified from the autolytic digest of cell walls.
Topics: Alanine; Ammonia; Antigens; Bacteriolysis; Cell Wall; Chromatography, Gas; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis; Glucosamine; Glucose; Glutamates; Hexosamines; Lysine; Organophosphonates; Phosphorus; Precipitin Tests; Rhamnose; Ribose; Streptococcus; Ultracentrifugation | 1967 |
Histidine 450 plays a critical role in catalysis and, with Ca2+, contributes to the substrate specificity of aminopeptidase A.
Topics: Amino Acid Sequence; Aminopeptidases; Animals; Asparagine; Calcium; Catalysis; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Glutamates; Glutamyl Aminopeptidase; Histidine; Humans; Lysine; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Organophosphonates; Rats; Recombinant Proteins; Substrate Specificity; Sulfhydryl Compounds | 2000 |
Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
Topics: Aconitate Hydratase; Amino Acid Sequence; Antibodies, Catalytic; Antibody Specificity; Antigens; Autoantibodies; Binding Sites, Antibody; Esters; Haptens; Humans; Immunoglobulin G; Immunoglobulin Light Chains; Lysine; Molecular Conformation; Molecular Sequence Data; Organophosphonates; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Vasoactive Intestinal Peptide | 2004 |
The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.
Topics: Adenine; Amino Acid Substitution; Anti-HIV Agents; Arginine; Didanosine; Dideoxynucleosides; Drug Resistance, Multiple, Viral; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lysine; Organophosphonates; Phenotype; Point Mutation; Reverse Transcriptase Inhibitors; Tenofovir; Thymidine; Zalcitabine; Zidovudine | 2006 |
Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors.
Topics: Adenine; Amino Acid Substitution; Anti-HIV Agents; Cytidine Triphosphate; Dideoxynucleosides; Dideoxynucleotides; Drug Resistance, Multiple, Viral; Genotype; Glutamic Acid; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Lysine; Mutagenesis, Site-Directed; Organophosphonates; Phenotype; Reverse Transcriptase Inhibitors; Tenofovir; Thymine Nucleotides; Zidovudine | 2007 |
Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
Topics: Animals; Aspartic Acid Endopeptidases; Benzofurans; Blood Glucose; Body Weight; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Enzyme Inhibitors; Glycopeptides; Heart; Lipids; Lysine; Male; Metalloendopeptidases; Myocardium; Oligopeptides; Organ Size; Organophosphonates; Peptides, Cyclic; Perfusion; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Thiorphan; Vasoconstriction | 2010 |
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure.
Topics: Adenine; Anti-HIV Agents; APOBEC Deaminases; Cytidine Deaminase; Cytosine Deaminase; DNA Mutational Analysis; Drug Resistance, Viral; Female; Glutamic Acid; HIV Reverse Transcriptase; HIV-1; Humans; Isoleucine; Lysine; Male; Methionine; Mutation; Nitriles; Organophosphonates; Pyridazines; Pyrimidines; Rilpivirine; Tenofovir; Treatment Failure; Virus Replication | 2012 |
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen.
Topics: Adenine; Adult; Arginine; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Viral; Female; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lysine; Male; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; South Africa; Stavudine; Tenofovir; Treatment Failure; Viral Load | 2012 |
Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?
Topics: Adenine; Adult; Anti-HIV Agents; Asparagine; Deoxycytidine; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; HIV Seropositivity; HIV-1; Humans; Lysine; Male; Mutation; Nitriles; Organophosphonates; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir | 2013 |
Synthesis of an activated phosphonated bifunctional chelate with potential for PET imaging and radiotherapy.
Topics: Antibodies, Monoclonal; Biopsy; Chelating Agents; Colonic Neoplasms; Cysteine; Ethylamines; Fluorescent Antibody Technique; Humans; Hydrogen-Ion Concentration; Hydrolysis; Lysine; Multimodal Imaging; Neoplasm Proteins; Organophosphonates; Peptides; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Spectrometry, Fluorescence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staining and Labeling; Tenascin; Tomography, X-Ray Computed | 2012 |
Phosphonate-based irreversible inhibitors of human γ-glutamyl transpeptidase (GGT). GGsTop is a non-toxic and highly selective inhibitor with critical electrostatic interaction with an active-site residue Lys562 for enhanced inhibitory activity.
Topics: Catalytic Domain; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia coli; gamma-Glutamyltransferase; Humans; Lysine; Models, Molecular; Molecular Structure; Organophosphonates; Static Electricity; Structure-Activity Relationship | 2016 |
Transition States and Control of Substrate Preference in the Promiscuous Phosphatase PP1.
Topics: Amino Acid Substitution; Arginine; Binding, Competitive; Biocatalysis; Catalytic Domain; Enzyme Inhibitors; Enzyme Stability; Evolution, Molecular; Humans; Hydrogen Bonding; Hydrolysis; Ligands; Lysine; Models, Molecular; Molecular Conformation; Mutagenesis, Site-Directed; Mutation; Nitrophenols; Organophosphonates; Organophosphorus Compounds; Organothiophosphorus Compounds; Protein Phosphatase 1; Recombinant Proteins; Substrate Specificity | 2017 |
Mono- and Bivalent 14-3-3 Inhibitors for Characterizing Supramolecular "Lysine Wrapping" of Oligoethylene Glycol (OEG) Moieties in Proteins.
Topics: 14-3-3 Proteins; Crystallization; Ethers; Lysine; Models, Molecular; Organophosphonates; Polyethylene Glycols; Protein Binding; Protein Multimerization; Proteins; Thermodynamics | 2018 |
Proton Conductive Zr-Phosphonate UPG-1-Aminoacid Insertion as Proton Carrier Stabilizer.
Topics: Adsorption; Hydrophobic and Hydrophilic Interactions; Lysine; Metal-Organic Frameworks; Organophosphonates; Porosity; Protons; Temperature; Thermogravimetry; Water; Zinc | 2020 |